Home › Mantle Cell Lymphoma › North Carolina › Durham
Pag-aaral pangklinika para sa Mantle Cell Lymphoma sa Durham, NC
Isang pag-aaral para sa Mantle Cell Lymphoma ang naghahanap ng mga kalahok sa isang site sa loob o malapit sa Durham. Buksan ito upang makita kung sino ang makakasali at kung paano makipag-ugnayan sa koponan ng pag-aaral.
Opisyal na teksto ng pag-aaral (English)
Testing Continuous Versus Intermittent Treatment With the Study Drug Zanubrutinib for Older Patients With Previously Untreated Mantle Cell Lymphoma
Nagre-recruitPhase 3
- Duke University Medical Center, Durham
- UNC Lineberger Comprehensive Cancer Center, Chapel Hill · 10 mi ang layo
A Study to Investigate the Efficacy and Safety of Sonrotoclax Plus Zanubrutinib Compared With Placebo Plus Zanubrutinib in Adults With Relapsed/Refractory Mantle Cell Lymphoma (CELESTIAL-RRMCL)
Nagre-recruitPhase 3
- Duke University, Durham
Gene Therapy for CD19-Positive Hematologic Malignancies (SENTRY-CD19)
Nagre-recruitPhase 1/2
- University of North Carolina at Chapel Hill/ University of North Carolina Medical Center, Chapel Hill · 10 mi ang layo
DALY II USA/ MB-CART2019.1 for DLBCL
Nagre-recruitPhase 2
- Duke University Medical Center - Division of Hematologic Malignancies, Durham
A Study of NX-5948 in Adults With Relapsed/Refractory B-cell Malignancies
Nagre-recruitPhase 1
- Duke University Medical Center, Durham
Registry of Older Patients With Cancer
Nagre-recruitObservasyonal na pag-aaral
- Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill, Chapel Hill · 10 mi ang layo
Study of Oral Administration of LP-168 in Patients With Relapsed or Refractory B-cell Malignancies.
Nagre-recruitPhase 1
- Duke Univerisity, Durham
Study of SGR-1505 in Mature B-Cell Neoplasms
Nagre-recruitPhase 1
- Duke University, Durham
Study of Kappa Chimeric Antigen Receptor (CAR) T Lymphocytes Co-Expressing the Kappa and CD28 CARs for Relapsed/Refractory Kappa+ Non-Hodgkin Lymphoma and Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma.
Nagre-recruitPhase 1
- Lineberger Comprehensive Cancer Center at University of North Carolina, Chapel Hill · 10 mi ang layo
AS-1763 in Patients With Previously Treated CLL/SLL or Non-Hodgkin Lymphoma
Nagre-recruitPhase 1
- Duke University, Durham
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Nagre-recruitObservasyonal na pag-aaral
- Massive Bio SYNERGY-AI site, Chapel Hill · 10 mi ang layo
Tissue, Blood, and Body Fluid Sample Collection From Patients With Hematologic Cancer
Nagre-recruitObservasyonal na pag-aaral
- Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill, Chapel Hill · 10 mi ang layo
A Study of AC676 for the Treatment of Relapsed/Refractory B-Cell Malignancies
Nagre-recruitPhase 1
- University of North Carolina, Chapel Hill · 10 mi ang layo
Pag-aaral para sa Mantle Cell Lymphoma sa ibang lungsod
- Houston, TX15 pag-aaral
- Baldwin Park, CA15 pag-aaral
- New York City, NY12 pag-aaral
- Seattle, WA12 pag-aaral
- Milwaukee, WI12 pag-aaral
- Boston, MA11 pag-aaral
- Nashville, TN11 pag-aaral
- Columbus, OH11 pag-aaral
- Chicago, IL10 pag-aaral
- Rochester, MN9 pag-aaral
- Portland, OR9 pag-aaral
- St. Louis, MO8 pag-aaral
Iba pang pag-aaral sa Durham
- Kanser sa Suso64 pag-aaral
- Kanser (lahat ng uri)58 pag-aaral
- Non-Small Cell Lung Cancer39 pag-aaral
- Multiple Myeloma37 pag-aaral
- Acute Myeloid Leukemia33 pag-aaral
- Metastatic Cancer33 pag-aaral
- Kanser sa Prostate32 pag-aaral
- Kanser sa Baga32 pag-aaral
- Colorectal Cancer28 pag-aaral
- Kanser sa Ovary27 pag-aaral
- Chronic Lymphocytic Leukemia27 pag-aaral
- Pagkabigo ng Puso26 pag-aaral
Mula sa ClinicalTrials.gov, na-kuha noong Okt 6, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.